MedBright AI Announces Strategic Acquisition by Numinus Wellness
Plans name change to “Numinus Intelligence” leveraging its current revenue generating operations to AI-enable mental health clinics across the US
VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) announces execution of a letter of intent (the “LOI”) to be acquired by Numinus Wellness Inc. (“Numinus” ) (TSX:NUMI, OTCQX: NUMIF), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, by way of a statutory plan of arrangement (the “Proposed Transaction”).
Related news for (MBAIF)
- MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent
- MedBright AI Issues Clarifying News Release on Continuous Disclosure Record
- Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
- Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations